Medivir to present data for the combination of fostrox + Lenvima in HCC at ESMO GI ...Middle East

PR Newswire - News
STOCKHOLM, April 29, 2024 /PRNewswire/ -- Medivir AB (NASDAQ: MVIR) (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today that an abstract for the combination of fostroxacitabine bralpamide...

Hence then, the article about medivir to present data for the combination of fostrox lenvima in hcc at esmo gi was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Medivir to present data for the combination of fostrox + Lenvima in HCC at ESMO GI )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News